Human IgG1 kappa, Isotype Control

Human IgG1 kappa, Isotype Control is a humanized IgG-like monoclonal antibody and an isotype control antibody for human IgG1κ.

Human IgG1 (N297A) kappa Isotype Control is a human-mouse chimeric monoclonal antibody serving as an isotype control specifically for the human IgG1 (N297A)κ antibody.

Human IgG1 (F405L) kappa Isotype Control is a chimeric human-mouse monoclonal antibody serving as an isotype control for the human IgG1 (F405L)κ antibody.

Human IgG1 (S239D/I332E) kappa Isotype Control is a chimeric monoclonal antibody derived from human and mouse sequences, serving as an isotype control for the Human IgG1 (S239D/I332E)κ antibody.

Human IgG1 (K214R) kappa Isotype Control is a chimeric monoclonal antibody that serves as an isotype control for the human IgG1 (K214R)κ antibody.

Human IgG1 (D270N) kappa Isotype Control is a chimeric human-mouse monoclonal antibody that serves as an isotype control for the human IgG1 (D270N)κ antibody.

Human IgG1 (D265A) kappa Isotype Control is a chimeric monoclonal antibody derived from both human and mouse, designed to serve as an isotype control for the human IgG1 (D265A)κ antibody.

HumanIgG1(L234F/L235E/P331S) kappa, Isotype Control, is a human-derived antibody and serves as the isotype control for the HumanIgG1(L234F/L235E/P331S)κ antibody.

HumanIgG1(L234AL235A) kappa, Isotype Control is a human monoclonal antibody that serves as an isotype control for human IgG1κ antibodies.

FF-21101 is a human IgG1 monoclonal antibody (mAb) that specifically targets CDH3/P-cadherin. It is suggested to use the isotype control, Human IgG1 kappa, for reference.

hu3S193 is a human IgG monoclonal antibody (mAb) that specifically targets Lewis Y. It exhibits excellent immune effector functions, including complement-dependent cytotoxicity (IC50: 1.0 μg/ml) and antibody-dependent cytotoxicity (IC50: 5.0 μg/ml). hu3S193 is applicable in research on small cell lung cancer (SCLC). The recommended isotype control is Human IgG1 kappa, Isotype Control.

VIR-7229 is a human IgG1 monoclonal antibody that targets the Receptor-Binding Domain (RBD) of the Spike glycoprotein. It exhibits antiviral activity by competing with ACE2 for binding and inducing the shedding of the S1 protein. VIR-7229 is applicable for research on SARS-CoV-2 infections. Recommended isotype control: Human IgG1 kappa, Isotype Control.

LASN01 is a human IgG1 monoclonal antibody targeting IL-11RA. It inhibits the release of hyaluronic acid (HA) induced by IGF-1 and IL-11 in orbital fibroblasts, as well as TGFβ-stimulated procollagen. LASN01 is applicable for research on thyroid eye disease (TED). Recommended isotype control: Human IgG1 kappa, Isotype Control.

VIR-8190 is a human IgG1 monoclonal antibody targeting the fusion glycoprotein F0. It is utilized in the study of respiratory syncytial virus (RSV) and metapneumovirus infections. The recommended isotype control is Human IgG1 kappa [Isotype Control].

VGL101 is a human IgG1 monoclonal antibody (mAb) that targets TREM-2. It acts as a pSYK agonist with an EC50 of 0.77 nM. Under ALSP pathological conditions, VGL101 enhances the survival of microglia and monocyte-derived macrophages, inhibits apoptosis, and aids in restoring cell morphology to resemble the normal activated CSF1R state. It is applicable in leukoencephalopathy research. Recommended isotype control: Human IgG1 kappa, Isotype Control.

GSK2831781 is a human IgG1 monoclonal antibody (mAb) designed to target CD223/LAG3. This compound is applicable in research studies focused on ulcerative colitis. For experimental controls, the recommended isotype control is Human IgG1 kappa.

Sigvotatug (Biotinylated) is the biotinylated derivative of Sigvotatug. It functions as a human IgG1κ monoclonal antibody inhibitor targeting ITGB6. The isotype control for Sigvotatug is Human IgG1 kappa, Isotype Control.

AB-3A4 is a human IgG1 monoclonal antibody (mAb) that targets KAAG1. It is applicable for research on ovarian cancer, triple-negative breast cancer, and prostate cancer. The recommended isotype control is Human IgG1 kappa, Isotype Control.

DNL-919 (TAK-920) is a human IgG1 monoclonal antibody (mAb) that targets TREM-2. It is utilized in Alzheimer's disease research. The recommended isotype control is Human IgG1 kappa, Isotype Control.

AGEN-1571 is a human IgG1 monoclonal antibody (mAb) targeting ILT2. It enhances both adaptive and innate immune responses. The recommended isotype control for this compound is Human IgG1 kappa, Isotype Control.

IPH5201 is a human IgG1 monoclonal antibody (mAb) targeting ENTPD1/CD39. It enhances the accumulation of immunostimulatory ATP released by tumor cells undergoing combination chemotherapy (CT) and reduces the levels of immunosuppressive adenosine (Ado) in the tumor microenvironment (TME). IPH5201 is useful for research on antitumor immunity. Recommended isotype control: Human IgG1 kappa, Isotype Control.

IO-106 is a human IgG1 monoclonal antibody (mAb) that targets LAIR1/CD305. The recommended isotype control is Human IgG1 kappa, Isotype Control.

MEDI-8852 is a human IgG1 monoclonal antibody (mAb) that specifically targets the influenza A virus hemagglutinin HA. It is used in research related to influenza A virus infections. The recommended isotype control for comparison is Human IgG1 kappa, Isotype Control.

Mik-Beta-1 is a human IgG1-kappa monoclonal antibody targeting IL2RB. For isotype control, refer to Human IgG1 kappa, Isotype Control. Mik-Beta-1 is applicable in research related to the prevention of allograft rejection.